Literature DB >> 10544293

Purification and characterization of a novel isoform of myosinase from spear squid liver.

J Tamori1, N Kanzawa, T Tajima, T Tamiya, T Tsuchiya.   

Abstract

A novel isoform of myosinase was purified to homogeneity from liver of spear squid by sequential chromatographies using SP Sephadex, hydroxylapatite, Zn/Co chelating affinity, and TSK-gel G2000SW columns. Myosinase activity was detected as a single peak of 45-kDa protein by gel filtration. The novel isoform of myosinase specifically hydrolyzed a rabbit skeletal muscle myosin heavy chain into products of 120 and 100 kDa in the presence of Co(2+) ions, and the cleavage site in the myosin heavy chain was quite different from those of two known myosinase isoforms, I and II. Therefore, we named the novel isoform myosinase III. Myosinase III was also distinguishable from myosinase I by its amino-terminal sequence. The sequence showed similarity to an internal sequence of the astacin family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544293     DOI: 10.1093/oxfordjournals.jbchem.a022542

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death.

Authors:  Junko Tsuji; Travis Thomson; Elizabeth Chan; Christine K Brown; Julia Oppenheimer; Carol Bigelow; Xianjun Dong; William E Theurkauf; Zhiping Weng; Lawrence M Schwartz
Journal:  Physiol Genomics       Date:  2020-09-14       Impact factor: 3.107

2.  Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates.

Authors:  Christoph Becker-Pauly; Olivier Barré; Oliver Schilling; Ulrich Auf dem Keller; Anke Ohler; Claudia Broder; André Schütte; Reinhild Kappelhoff; Walter Stöcker; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2011-06-21       Impact factor: 5.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.